Department of General Surgery, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, 510515, Guangzhou, China.
Surg Endosc. 2019 Jan;33(1):135-144. doi: 10.1007/s00464-018-6283-0. Epub 2018 Jun 25.
Laparoscopy-assisted distal gastrectomy (LADG) for gastric cancer has been widely applied; however, its oncologic efficacy has yet been well established. The study aimed to compare the long-term oncologic outcomes of LADG versus open distal gastrectomy (ODG) on gastric cancer.
The clinicopathologic data of gastric cancer patients who underwent distal gastrectomy with curative intent from October 2004 through September 2014 were included and analyzed in a retrospective cohort. The last follow-up was September 2016.
769 eligible patients (LADG 414 vs. ODG 355) were included in the study. No significant difference was observed between the groups in 5-year DFS (LADG 61.2% vs. ODG 59.1%; p = 0.384) and OS rates (LADG 65.8% vs. ODG 66.3%; p = 0.750). During surgery, though LADG group had longer operating time, the blood loss was less than ODG group. LADG group had faster postoperative recovery course including shorter time to oral intake, ambulation, and discharge time. Postoperative complication rate within 30 days showed no significant difference between the groups (LADG 15.7% vs. ODG 13.0%; p = 0.281). Age over 65 years old, blood loss > 200 ml, postoperative complication, and advanced T and N stage were identified as independent risk factors for DFS and OS.
LADG could yield similar oncologic outcomes compared with ODG in treating distal gastric cancer. However, the findings need to be further confirmed through ongoing prospective randomized controlled trials.
腹腔镜辅助远端胃切除术(LADG)已广泛应用于胃癌治疗,但 LADG 的肿瘤学疗效尚未得到充分证实。本研究旨在比较 LADG 与开腹远端胃切除术(ODG)治疗胃癌的长期肿瘤学结果。
回顾性分析 2004 年 10 月至 2014 年 9 月期间接受根治性远端胃切除术的胃癌患者的临床病理资料。最后一次随访时间为 2016 年 9 月。
本研究共纳入 769 例符合条件的患者(LADG 组 414 例,ODG 组 355 例)。两组患者 5 年无病生存率(LADG 组 61.2%,ODG 组 59.1%;p=0.384)和总生存率(LADG 组 65.8%,ODG 组 66.3%;p=0.750)差异无统计学意义。手术过程中,虽然 LADG 组的手术时间较长,但出血量少于 ODG 组。LADG 组术后恢复较快,包括开始口服饮食、下床活动和出院的时间均较短。两组术后 30 天内并发症发生率差异无统计学意义(LADG 组 15.7%,ODG 组 13.0%;p=0.281)。年龄>65 岁、出血量>200ml、术后并发症以及肿瘤进展期 T 和 N 期是无病生存和总生存的独立危险因素。
与 ODG 相比,LADG 治疗远端胃癌可获得相似的肿瘤学结果。然而,这些发现需要通过正在进行的前瞻性随机对照试验进一步证实。